Reduction of oesophageal toxicity with VMAT dose-sparing radiotherapy in thoracic metastatic spinal cord compression: A feasibility study
Background: Palliative radiotherapy for metastatic spinal cord compression (MSCC) is given to halt disease progression and sustain quality of life for patients with advanced cancer. Radiotherapy can however induce toxicity, contradicting treatment intention. Advanced radiotherapy offers possibility...
Main Authors: | Vanja Remberg Gram, Daniel Gram, Gitte Fredberg Persson, Morten Hiul Suppli, Sarah Barrett |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-09-01
|
Series: | Technical Innovations & Patient Support in Radiation Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405632422000208 |
Similar Items
-
Best Supportive Care of the Patient with Oesophageal Cancer
by: Rita Carrilho Pichel, et al.
Published: (2022-12-01) -
Oesophageal duplication – An uncommon cause of dysphagia in an adult
by: Ankita Singh, et al.
Published: (2022-01-01) -
Chemoradiotherapy with concurrent durvalumab for the palliative treatment of oligometastatic oesophageal and gastrooesophageal carcinoma with dysphagia: a single arm phase II clinical trial (PALEO, sponsored by the Australasian Gastro-Intestinal Trials Group)
by: Fiona Day, et al.
Published: (2022-12-01) -
Eosinophilic oesophagitis
by: Hanna Sikorska-Szaflik
Published: (2016-09-01) -
Feasibility of hippocampus-sparing VMAT for newly diagnosed glioblastoma treated by chemoradiation: pattern of failure analysis
by: Chan Woo Wee, et al.
Published: (2020-05-01)